Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines
Titel:
Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines
Auteur:
Qian, Xiao-Long Wen, Hannah Y. Yang, Yi-Ling Gu, Feng Guo, Xiao-Jing Liu, Fang-Fang Zhang, Lanjing Zhang, Xin-Min Fu, Li